Detailed TOC of Global Plasma-derived Medicinal Products Market Research Report 2021
1 Plasma-derived Medicinal Products Market Overview1.1 Product Overview and Scope of Plasma-derived Medicinal Products
1.2 Plasma-derived Medicinal Products Segment by Type
1.2.1 Global Plasma-derived Medicinal Products Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Immunoglobulins
1.2.3 Coagulation Factor Concentrates
1.2.4 Other
1.3 Plasma-derived Medicinal Products Segment by Application
1.3.1 Global Plasma-derived Medicinal Products Sales Comparison by Application: (2021-2027)
1.3.2 Emergency Care
1.3.3 Epidemic Diseasae
1.3.4 Immune System Disorder
1.3.5 Antibody Deficiency
1.3.6 Coagulation Disorder
1.3.7 Others
1.4 Global Plasma-derived Medicinal Products Market Size Estimates and Forecasts
1.4.1 Global Plasma-derived Medicinal Products Revenue 2016-2027
1.4.2 Global Plasma-derived Medicinal Products Sales 2016-2027
1.4.3 Plasma-derived Medicinal Products Market Size by Region: 2016 Versus 2021 Versus 2027
2 Plasma-derived Medicinal Products Market Competition by Manufacturers
2.1 Global Plasma-derived Medicinal Products Sales Market Share by Manufacturers (2016-2021)
2.2 Global Plasma-derived Medicinal Products Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Plasma-derived Medicinal Products Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Plasma-derived Medicinal Products Manufacturing Sites, Area Served, Product Type
2.5 Plasma-derived Medicinal Products Market Competitive Situation and Trends
2.5.1 Plasma-derived Medicinal Products Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Plasma-derived Medicinal Products Players Market Share by Revenue
2.5.3 Global Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plasma-derived Medicinal Products Retrospective Market Scenario by Region
3.1 Global Plasma-derived Medicinal Products Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Plasma-derived Medicinal Products Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Plasma-derived Medicinal Products Market Facts & Figures by Country
3.3.1 North America Plasma-derived Medicinal Products Sales by Country
3.3.2 North America Plasma-derived Medicinal Products Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Plasma-derived Medicinal Products Market Facts & Figures by Country
3.4.1 Europe Plasma-derived Medicinal Products Sales by Country
3.4.2 Europe Plasma-derived Medicinal Products Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Plasma-derived Medicinal Products Market Facts & Figures by Region
3.5.1 Asia Pacific Plasma-derived Medicinal Products Sales by Region
3.5.2 Asia Pacific Plasma-derived Medicinal Products Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Plasma-derived Medicinal Products Market Facts & Figures by Country
3.6.1 Latin America Plasma-derived Medicinal Products Sales by Country
3.6.2 Latin America Plasma-derived Medicinal Products Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Plasma-derived Medicinal Products Market Facts & Figures by Country
3.7.1 Middle East and Africa Plasma-derived Medicinal Products Sales by Country
3.7.2 Middle East and Africa Plasma-derived Medicinal Products Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Plasma-derived Medicinal Products Historic Market Analysis by Type
4.1 Global Plasma-derived Medicinal Products Sales Market Share by Type (2016-2021)
4.2 Global Plasma-derived Medicinal Products Revenue Market Share by Type (2016-2021)
4.3 Global Plasma-derived Medicinal Products Price by Type (2016-2021)
5 Global Plasma-derived Medicinal Products Historic Market Analysis by Application
5.1 Global Plasma-derived Medicinal Products Sales Market Share by Application (2016-2021)
5.2 Global Plasma-derived Medicinal Products Revenue Market Share by Application (2016-2021)
5.3 Global Plasma-derived Medicinal Products Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Novartis(CSL Limited)
6.1.1 Novartis(CSL Limited) Corporation Information
6.1.2 Novartis(CSL Limited) Description and Business Overview
6.1.3 Novartis(CSL Limited) Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis(CSL Limited) Plasma-derived Medicinal Products Product Portfolio
6.1.5 Novartis(CSL Limited) Recent Developments/Updates
6.2 Biotest AG (Creat Group Corporation)
6.2.1 Biotest AG (Creat Group Corporation) Corporation Information
6.2.2 Biotest AG (Creat Group Corporation) Description and Business Overview
6.2.3 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product Portfolio
6.2.5 Biotest AG (Creat Group Corporation) Recent Developments/Updates
6.3 Grifols SA
6.3.1 Grifols SA Corporation Information
6.3.2 Grifols SA Description and Business Overview
6.3.3 Grifols SA Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Grifols SA Plasma-derived Medicinal Products Product Portfolio
6.3.5 Grifols SA Recent Developments/Updates
6.4 Sigma-Aldrich
6.4.1 Sigma-Aldrich Corporation Information
6.4.2 Sigma-Aldrich Description and Business Overview
6.4.3 Sigma-Aldrich Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sigma-Aldrich Plasma-derived Medicinal Products Product Portfolio
6.4.5 Sigma-Aldrich Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Corporation Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Thermo Fisher Scientific Plasma-derived Medicinal Products Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Octapharma AG
6.6.1 Octapharma AG Corporation Information
6.6.2 Octapharma AG Description and Business Overview
6.6.3 Octapharma AG Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Octapharma AG Plasma-derived Medicinal Products Product Portfolio
6.6.5 Octapharma AG Recent Developments/Updates
6.7 Takeda
6.6.1 Takeda Corporation Information
6.6.2 Takeda Description and Business Overview
6.6.3 Takeda Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Plasma-derived Medicinal Products Product Portfolio
6.7.5 Takeda Recent Developments/Updates
6.8 Kedrion
6.8.1 Kedrion Corporation Information
6.8.2 Kedrion Description and Business Overview
6.8.3 Kedrion Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Kedrion Plasma-derived Medicinal Products Product Portfolio
6.8.5 Kedrion Recent Developments/Updates
6.9 China Biologic Products
6.9.1 China Biologic Products Corporation Information
6.9.2 China Biologic Products Description and Business Overview
6.9.3 China Biologic Products Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China Biologic Products Plasma-derived Medicinal Products Product Portfolio
6.9.5 China Biologic Products Recent Developments/Updates
6.10 LFB Group
6.10.1 LFB Group Corporation Information
6.10.2 LFB Group Description and Business Overview
6.10.3 LFB Group Plasma-derived Medicinal Products Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LFB Group Plasma-derived Medicinal Products Product Portfolio
6.10.5 LFB Group Recent Developments/Updates
7 Plasma-derived Medicinal Products Manufacturing Cost Analysis
7.1 Plasma-derived Medicinal Products Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Plasma-derived Medicinal Products
7.4 Plasma-derived Medicinal Products Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Plasma-derived Medicinal Products Distributors List
8.3 Plasma-derived Medicinal Products Customers
9 Plasma-derived Medicinal Products Market Dynamics
9.1 Plasma-derived Medicinal Products Industry Trends
9.2 Plasma-derived Medicinal Products Growth Drivers
9.3 Plasma-derived Medicinal Products Market Challenges
9.4 Plasma-derived Medicinal Products Market Restraints
10 Global Market Forecast
10.1 Plasma-derived Medicinal Products Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Plasma-derived Medicinal Products by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Plasma-derived Medicinal Products by Type (2022-2027)
10.2 Plasma-derived Medicinal Products Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Plasma-derived Medicinal Products by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Plasma-derived Medicinal Products by Application (2022-2027)
10.3 Plasma-derived Medicinal Products Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Plasma-derived Medicinal Products by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Plasma-derived Medicinal Products by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Plasma-derived Medicinal Products Market Research Report 2021
List of TablesTable 1. Global Plasma-derived Medicinal Products Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Plasma-derived Medicinal Products Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Plasma-derived Medicinal Products Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Plasma-derived Medicinal Products Covered in This Study
Table 5. Global Plasma-derived Medicinal Products Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Plasma-derived Medicinal Products Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Plasma-derived Medicinal Products Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Plasma-derived Medicinal Products Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Plasma-derived Medicinal Products Manufacturing Sites and Area Served
Table 11. Manufacturers Plasma-derived Medicinal Products Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Plasma-derived Medicinal Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma-derived Medicinal Products as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Plasma-derived Medicinal Products Sales by Region (2016-2021) & (K Units)
Table 16. Global Plasma-derived Medicinal Products Sales Market Share by Region (2016-2021)
Table 17. Global Plasma-derived Medicinal Products Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 19. North America Plasma-derived Medicinal Products Sales Market Share by Country (2016-2021)
Table 20. North America Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2021)
Table 22. Europe Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 23. Europe Plasma-derived Medicinal Products Sales Market Share by Country (2016-2021)
Table 24. Europe Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Plasma-derived Medicinal Products Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Plasma-derived Medicinal Products Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Plasma-derived Medicinal Products Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2021)
Table 30. Latin America Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Plasma-derived Medicinal Products Sales Market Share by Country (2016-2021)
Table 32. Latin America Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Plasma-derived Medicinal Products Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Plasma-derived Medicinal Products Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Plasma-derived Medicinal Products Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Plasma-derived Medicinal Products Revenue Market Share by Country (2016-2021)
Table 38. Global Plasma-derived Medicinal Products Sales (K Units) by Type (2016-2021)
Table 39. Global Plasma-derived Medicinal Products Sales Market Share by Type (2016-2021)
Table 40. Global Plasma-derived Medicinal Products Revenue (Million US$) by Type (2016-2021)
Table 41. Global Plasma-derived Medicinal Products Revenue Share by Type (2016-2021)
Table 42. Global Plasma-derived Medicinal Products Price (US$/Unit) by Type (2016-2021)
Table 43. Global Plasma-derived Medicinal Products Sales (K Units) by Application (2016-2021)
Table 44. Global Plasma-derived Medicinal Products Sales Market Share by Application (2016-2021)
Table 45. Global Plasma-derived Medicinal Products Revenue (Million US$) by Application (2016-2021)
Table 46. Global Plasma-derived Medicinal Products Revenue Share by Application (2016-2021)
Table 47. Global Plasma-derived Medicinal Products Price (US$/Unit) by Application (2016-2021)
Table 48. Novartis(CSL Limited) Corporation Information
Table 49. Novartis(CSL Limited) Description and Business Overview
Table 50. Novartis(CSL Limited) Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Novartis(CSL Limited) Plasma-derived Medicinal Products Product
Table 52. Novartis(CSL Limited) Recent Developments/Updates
Table 53. Biotest AG (Creat Group Corporation) Corporation Information
Table 54. Biotest AG (Creat Group Corporation) Description and Business Overview
Table 55. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Biotest AG (Creat Group Corporation) Plasma-derived Medicinal Products Product
Table 57. Biotest AG (Creat Group Corporation) Recent Developments/Updates
Table 58. Grifols SA Corporation Information
Table 59. Grifols SA Description and Business Overview
Table 60. Grifols SA Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Grifols SA Plasma-derived Medicinal Products Product
Table 62. Grifols SA Recent Developments/Updates
Table 63. Sigma-Aldrich Corporation Information
Table 64. Sigma-Aldrich Description and Business Overview
Table 65. Sigma-Aldrich Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sigma-Aldrich Plasma-derived Medicinal Products Product
Table 67. Sigma-Aldrich Recent Developments/Updates
Table 68. Thermo Fisher Scientific Corporation Information
Table 69. Thermo Fisher Scientific Description and Business Overview
Table 70. Thermo Fisher Scientific Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Thermo Fisher Scientific Plasma-derived Medicinal Products Product
Table 72. Thermo Fisher Scientific Recent Developments/Updates
Table 73. Octapharma AG Corporation Information
Table 74. Octapharma AG Description and Business Overview
Table 75. Octapharma AG Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Octapharma AG Plasma-derived Medicinal Products Product
Table 77. Octapharma AG Recent Developments/Updates
Table 78. Takeda Corporation Information
Table 79. Takeda Description and Business Overview
Table 80. Takeda Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Takeda Plasma-derived Medicinal Products Product
Table 82. Takeda Recent Developments/Updates
Table 83. Kedrion Corporation Information
Table 84. Kedrion Description and Business Overview
Table 85. Kedrion Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Kedrion Plasma-derived Medicinal Products Product
Table 87. Kedrion Recent Developments/Updates
Table 88. China Biologic Products Corporation Information
Table 89. China Biologic Products Description and Business Overview
Table 90. China Biologic Products Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. China Biologic Products Plasma-derived Medicinal Products Product
Table 92. China Biologic Products Recent Developments/Updates
Table 93. LFB Group Corporation Information
Table 94. LFB Group Description and Business Overview
Table 95. LFB Group Plasma-derived Medicinal Products Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. LFB Group Plasma-derived Medicinal Products Product
Table 97. LFB Group Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Plasma-derived Medicinal Products Distributors List
Table 101. Plasma-derived Medicinal Products Customers List
Table 102. Plasma-derived Medicinal Products Market Trends
Table 103. Plasma-derived Medicinal Products Growth Drivers
Table 104. Plasma-derived Medicinal Products Market Challenges
Table 105. Plasma-derived Medicinal Products Market Restraints
Table 106. Global Plasma-derived Medicinal Products Sales Forecast by Type (2022-2027) & (K Units)
Table 107. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Plasma-derived Medicinal Products Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Plasma-derived Medicinal Products Sales Forecast by Application (2022-2027) & (K Units)
Table 111. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Plasma-derived Medicinal Products Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Plasma-derived Medicinal Products Sales Forecast by Region (2022-2027) & (K Units)
Table 115. Global Plasma-derived Medicinal Products Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Plasma-derived Medicinal Products Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Plasma-derived Medicinal Products Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plasma-derived Medicinal Products
Figure 2. Global Plasma-derived Medicinal Products Market Share by Type in 2020 & 2027
Figure 3. Immunoglobulins Product Picture
Figure 4. Coagulation Factor Concentrates Product Picture
Figure 5. Other Product Picture
Figure 6. Global Plasma-derived Medicinal Products Market Share by Application in 2020 & 2027
Figure 7. Emergency Care
Figure 8. Epidemic Diseasae
Figure 9. Immune System Disorder
Figure 10. Antibody Deficiency
Figure 11. Coagulation Disorder
Figure 12. Others
Figure 13. Global Plasma-derived Medicinal Products Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Plasma-derived Medicinal Products Market Size 2016-2027 (US$ Million)
Figure 15. Global Plasma-derived Medicinal Products Sales 2016-2027 (K Units)
Figure 16. Global Plasma-derived Medicinal Products Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Plasma-derived Medicinal Products Sales Share by Manufacturers in 2020
Figure 18. Global Plasma-derived Medicinal Products Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Plasma-derived Medicinal Products Players: Market Share by Revenue in 2020
Figure 20. Plasma-derived Medicinal Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Plasma-derived Medicinal Products Sales Market Share by Region (2016-2021)
Figure 22. Global Plasma-derived Medicinal Products Sales Market Share by Region in 2020
Figure 23. Global Plasma-derived Medicinal Products Revenue Market Share by Region (2016-2021)
Figure 24. Global Plasma-derived Medicinal Products Revenue Market Share by Region in 2020
Figure 25. United States Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. China Taiwan Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Plasma-derived Medicinal Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Plasma-derived Medicinal Products by Type (2016-2021)
Figure 48. Sales Market Share of Plasma-derived Medicinal Products by Application (2016-2021)
Figure 49. Sales Market Share of Plasma-derived Medicinal Products by Application in 2020
Figure 50. Revenue Share of Plasma-derived Medicinal Products by Application (2016-2021)
Figure 51. Revenue Share of Plasma-derived Medicinal Products by Application in 2020
Figure 52. Manufacturing Cost Structure of Plasma-derived Medicinal Products
Figure 53. Manufacturing Process Analysis of Plasma-derived Medicinal Products
Figure 54. Plasma-derived Medicinal Products Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Keyplayers in Global Plasma-derived Medicinal Products Market Research Report 2021
Novartis(CSL Limited)Biotest AG (Creat Group Corporation)
Grifols SA
Sigma-Aldrich
Thermo Fisher Scientific
Octapharma AG
Takeda
Kedrion
China Biologic Products
LFB Group